ISPOR - Factors Influencing the Pharmacokinetics of Sunitinib and its Active Metabolite in MRCC Patients Receiving an Attenuated Sunitinib Dosing Regimen

Full Text

Factors Influencing the Pharmacokinetics of Sunitinib and its Active Metabolite in MRCC Patients Receiving an Attenuated Sunitinib Dosing Regimen

Abstract

Authors

J Chae

Back to Volume 19, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now